144

  • Internet havola
  • DOI
  • UzSCI tizimida yaratilgan sana 02-05-2020
  • O'qishlar soni 132
  • Nashr sanasi 07-10-2019
  • Asosiy tilRus
  • Sahifalar274-280
Kalit so'z
№ Havola nomi
1 1. Alexandrov P.N., Dua P., Hill J.M.et al. MicroRNA(miRNA) speciation in Alzheimer’s disease (AD) cerebrospinal !uid (CSF) and extracellular !uid (ECF) // Int. J. Biochem. Mol. Biol. - 2012. - V. 3. - P. 365–373. 2. Belzeaux R., Bergon A., Jeanjean V. et al. Responder and nonresponder patients exhibit di#erent peripheral transcriptional signatures during major depressive episode // Transl. Psychiatry. - 2012. - V. 2. - P. e185. 3. Bocchio-Chiavetto L., Maoletti E., Bettinsoli P. et al. Blood microRNA changes in depressed patients during antidepressant treatment// Eur. Neuropsychopharmacol. - 2013. - V. 23. - P. 602–611. 4. Chan A.W., Kocerha J. МicroRNA therapeutics in psychiatric and neurodegenerative disorders // Front. Genet. - 2012. - V. 3. - P. 82. 5. Chen X., Ba Y., Ma L. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases // Cell Res — 2008. - V. 18. - P. 997–1006. 6. Cogswell J.P., Ward J., Taylor I.A.et al. Identication of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways // J. Alzheimers Dis. - 2008. - V. 14. - P. 27–41. 7. Davis B.N., Hata A. Regulation of microRNA biogenesis: a miRiad of mechanisms // Cell Commun. Signal. - 2009. - V. 7. - P. 18. 8. Doxakis E. Post-transcriptional regulation of alphasynuclein expression by mir-7 and mir-153 // J. Biol. Chem. - 2010. - V. 285.- P. 12726–12734. 9. Farazi T.A., Hoell J.I., Morozov P.et al. MicroRNAs in human cancer // Adv. Exp. Med. Biol. - 2013. - V. 774. - P. 1–20. 10. Fichtlscherer S., DeRosa S., Fox H. et al. Circulating microRNAs in patients with coronary artery disease // Circ. Res. - 2010. - V. 107. - P. 677–684. 11. Gardiner E., Beveridge N.J., Wu J.Q. et al. Imprinted DLK1-DIO3 region of 14q32 denes as chizophrenia-associated miRNA signature in peripheral blood mononuclear cells // Mol. Psychiatry - 2012. - V. 17. - P. 827–840. 12. Hanke M., Hoeg K., Merz H. et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer // Urol. Oncol. - 2010. - V. 28. - P. 655–661. 13. Junn E., Lee K.W., Jeong B.S.et al.Repression of alpha-synuclein expression and toxicity by microRNA-7 // Proc. Natl. Acad. Sci. U.S.A. - 2009. - V. 106. - P. 13052–13057. 14. Junn E., Mouradian M.M. MicroRNAs in neurodegenerative diseases and their therapeutic potential // Pharmacol. - 2012. - V. 133. - P. 142–150. 15. Kim A.H., Reimers M., Maher B. et al. MicroRNA expression pro&ling in the prefrontal cortex of individuals a#ected with schizophrenia and bipolar disorders // Schizophr. Res. - 2010. - V. 124. - P. 183–191. 16. Kolshus E., Dalton, V.S., Ryan, K.M. When less is more microRNAs and psychiatric disorders. // Acta Psychiatr. Scand. - 2014. - V. 129. - P. 241–256. 17. Kroh, E.M., Parkin R.K., Mitchell P.S. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) // Methods. - 2010. - V. 50. - P. 298–301. 18. Krol J., Loedige I., Filipowicz W. Widespread regulation of microRNA biogenesis, function and decay // Nat. Rev. Genet. - 2010. - V. 11. - P. 597–610. 19. Lai C.Y., Yu S.L., Hsieh M.H. et al. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia // PLoS ONE - 2011. - V. 6. - P. e21635. 20. Lee R.C, Feinbaum R.L, Ambros V.C. Еlegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. // Cell - 1993. V. 75. - P. 843–854. 21. LiY. J., XuM., GaoZ.H. et al.Alterations of serum levels of BDNF- related miRNAs in patients with depression // PLoS ONE - 2013. V. 8. - P. e63648. 22. Liu S., Yuan Y.B., Guan L.L. et al. MiRNA-365 and miRNA-520c-3p respond to risperidone treatment in episode schizophrenia a+er a1year remission // Chin. Med. J. (Engl.). - 2013. V. 126, P. 2676–2680. 23. Madrigal-Matute J., Rotllan N., Aranda J.F.et al. Fernаndez-Hernando C. MicroRNAs and atherosclerosis // Curr. Atheroscler. Rep. - 2013. V. 15 (5), P. 322. 24. Margis R., Margis R., Rieder C.R. Identication of blood microRNAs associated to Parkinsonis disease // J. Biotechnol. - 2011. V. 152, P. 96–101. 25. Martins, M., Rosa A., Guedes L.C. et al. Convergence of miRNA expression pro&ling, α-synuclein interacton and GWAS in Parkinson’s disease // PLoS ONE - 2011. V. 6, P. e25443. 26. Miones-Moyano E., Porta S., Escaramís G.et al. MicroRNA pro&ling of Parkinson’s disease brains identi&es early downregulation of miR-34b/c which modulate mitochondrial function // Hum. Mol .Genet. - 2011. V. 20, P. 3067–3078. 27. Miller B.H., Zeier Z., Xi L. et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function // Proc. Natl. Acad. Sci. U.S.A. - 2012. V. 109, P. 3125–3130. 28. Mitchell P.S., Parkin R.K., Kroh E.M. et al. Circulating microRNAs as stable bloodbased markers for cancer detection // Proc. Natl. Acad. Sci. U.S.A. - 2008. V. 105, P. 10513–10518. 29. Moreau M.P., Bruse S.E., David-Rus R. et al. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder // Biol. Psychiatry - 2011. V. 69, P. 188–193. 30. Olde Loohuis N.F., Kos A., Martens G.J. et al. MicroRNA networks direct neuronal development and plasticity // Cell. Mol. Life Sci. - 2012. - V. 69. - P. 89–102. 31. Perkins D.O., Jeries C., Sullivan P. Expanding the central dogma: the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia // Mol. Psychiatry - 2005. V. 10. - P. 69–78. 32. RongH., LiuT.B., YangK.J. et al. MicroRNA-134 plasma levels before and a+er treatment for bipolar mania // J. Psychiatr. Res. -2011. V. 45. - P. 92–95. 33. Shi W., Du J., Qi Y. et al. Aberrant expression of serum miRNAs in schizophrenia // J. Psychiatr. Res. - 2012. V. 46 - P. 198–204. 34. Smalheiser N.R., Lugli G., Rizavi H.S. et al. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects // PLoS ONE - 2012. V. 7. - P. e33201. 35. Tan L., Yu J.T., Liu Q.Y. et al. Circulating miR-125b as a biomarker of Alzheimer’s disease // J. Neurol. Sci. - 2014. V. 336. - P. 52–56.
Kutilmoqda